StockStory Flags Clorox’s Sales and Cash-Flow Weaknesses
The publisher points to declining sales, modest organic growth and a lower free-cash-flow margin in its cautious assessment of Clorox.
Makkler Newsroom · Oct 13, 12:31 AM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $94.00 (-14.1%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO